A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy

The combination of chemodynamic therapy (CDT) and immunotherapy offers a promising therapeutic paradigm for advanced cancer treatment, yet its translation is largely hindered by inadequate intratumoral reactive oxygen species (ROS) production and the lack of a robust link between ROS-induced cytotoxicity and durable immune activation. To address these challenges, we herein engineer a multifunctional biomimetic nanoplatform (ZMGM) by encapsulating Mn2+ and glucose oxidase (GOX) within zeolitic imidazolate framework-8 (ZIF-8), followed by surface functionalization with 4T1 breast cancer cell membranes. This design integrates three synergistic functions: (1) GOX depletes glucose and generates hydrogen peroxide (H2O2) within the acidic tumor microenvironment; (2) the produced H2O2 fuels the Mn2+-mediated Fenton-like reaction to amplify ROS production; and (3) Mn2+ simultaneously serves as a potent stimulator of interferon genes (STING) agonist, triggering type-I interferon responses and promoting dendritic cell maturation. Meanwhile, the homologous cancer cell membrane coating endows ZMGM with specific tumor homing and enhanced tumor localization. Both in vitro and in vivo findings demonstrate that ZMGM not only efficiently eradicates primary tumors but also induces a systemic antitumor immune response, characterized by increased CD8+ T cell infiltration, that effectively suppresses distant metastatic lesions. Notably, the synergistic CDT-STING immunotherapy achieves a primary tumor inhibition rate of 84.22% without obvious systemic toxicity. This work provides a paradigm for rationally designing a single nanoplatform that bridges ROS-mediated cell killing and innate immune activation, offering a promising avenue for combating metastatic triple-negative breast cancer.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2026-11-12
DOI
https://doi.org/10.1021/acsami.6c15847
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy

Saira Shams, Khurshed A. Bozorov, Ghazala Ashraf, Qinghao Zhou et al.
ACS Applied Materials & Interfaces
Nanoplatforms for cancer theranostics
article

A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy

Saira Shams, Khurshed A. Bozorov, Ghazala Ashraf, Qinghao Zhou, Yuanyuan Ji, Zhishen Ge, Waqas Ahmad, Debabrata Dutta, Wasim Sajjad, Cheng Li
article en

Abstract

The combination of chemodynamic therapy (CDT) and immunotherapy offers a promising therapeutic paradigm for advanced cancer treatment, yet its translation is largely hindered by inadequate intratumoral reactive oxygen species (ROS) production and the lack of a robust link between ROS-induced cytotoxicity and durable immune activation. To address these challenges, we herein engineer a multifunctional biomimetic nanoplatform (ZMGM) by encapsulating Mn2+ and glucose oxidase (GOX) within zeolitic imidazolate framework-8 (ZIF-8), followed by surface functionalization with 4T1 breast cancer cell membranes. This design integrates three synergistic functions: (1) GOX depletes glucose and generates hydrogen peroxide (H2O2) within the acidic tumor microenvironment; (2) the produced H2O2 fuels the Mn2+-mediated Fenton-like reaction to amplify ROS production; and (3) Mn2+ simultaneously serves as a potent stimulator of interferon genes (STING) agonist, triggering type-I interferon responses and promoting dendritic cell maturation. Meanwhile, the homologous cancer cell membrane coating endows ZMGM with specific tumor homing and enhanced tumor localization. Both in vitro and in vivo findings demonstrate that ZMGM not only efficiently eradicates primary tumors but also induces a systemic antitumor immune response, characterized by increased CD8+ T cell infiltration, that effectively suppresses distant metastatic lesions. Notably, the synergistic CDT-STING immunotherapy achieves a primary tumor inhibition rate of 84.22% without obvious systemic toxicity. This work provides a paradigm for rationally designing a single nanoplatform that bridges ROS-mediated cell killing and innate immune activation, offering a promising avenue for combating metastatic triple-negative breast cancer.

ACS Applied Materials & Interfaces
University of Science and Technology of China (CN), Samarkand State University named after Sharof Rashidov (UZ), Northwestern Polytechnical University (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Xi'an Jiaotong University (CN)
Xi'an Jiaotong University, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities, Key Research and Development Projects of Shaanxi Province, Natural Science Basic Research Program of Shaanxi Province
Good health and well-being
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon